WebDisclosure WebDisclosure
Basculer en Français
10779 Companies
232607 Keywords
161119 Articles
123940 Press releases
Headlines Articles Press releases Valamis Remove
  1. Home
  2. Companies
  3. Valamis
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/03/2024 at 15:05, 2 years 3 months ago

    Valamis Unveils New Brand Identity to Spearhead Global L&D Innovation

    Innovation Brand Identity Corporate Strategy Valamis Learning & Development
  • BRIEF

    published on 04/03/2024 at 15:05, 2 years 3 months ago

    Valamis dévoile une nouvelle identité de marque pour diriger l'innovation mondiale en matière de formation et de développement

    Stratégie D'entreprise Innovation Identité De Marque Valamis Apprentissage Et Développement
  • PRESS RELEASE

    published on 04/03/2024 at 15:00, 2 years 3 months ago

    Valamis Reveals Fresh Brand Identity to Fuel Global Growth and Innovation in Learning & Development (L&D)

    Valamis announces the launch of its new brand identity, emphasizing innovation, customer success, and data-driven product philosophy for impactful learning and development. The move reflects a forward-thinking vision and commitment to continuous learning
    Innovation Brand Identity Valamis L&D Impact Continuous Learning
    Logo of Valamis
Accesswire
  • Published on 07/30/2026 at 04:10, 1 hour 29 minutes ago

    Pathfinder Ventures Announces Appointment of Mark Roseborough as Chief Executive Officer

  • Published on 07/30/2026 at 01:50, 3 hours 49 minutes ago

    Further Assays Infill Tunkillia Pit Extension Targets

  • Published on 07/30/2026 at 00:50, 4 hours 49 minutes ago

    Aton Announces Strategic Cooperation Relationship and Board Nominee

  • Published on 07/30/2026 at 00:00, 5 hours 39 minutes ago

    American Hotel Income Properties REIT LP to Host Second Quarter 2026 Results Conference Call on August 6, 2026

  • Published on 07/29/2026 at 23:01, 6 hours 38 minutes ago

    Blueberries Medical Announces C$1.1 Million Non-Brokered Private Placement

View all ACCESSWIRE
EQS Group
  • Published on 07/29/2026 at 21:45, 7 hours 53 minutes ago

    Piramal Pharma Limited Announces Results for Q1 FY27

  • Published on 07/29/2026 at 21:12, 8 hours 26 minutes ago

    Interim individual report for the period ending on 30.06.2026

  • Published on 07/29/2026 at 18:25, 11 hours 13 minutes ago

    International Fencing Federation prevails over Reuters in court - Court of Appeal prohibits false claims about the open letter to the IOC

  • Published on 07/29/2026 at 18:21, 11 hours 17 minutes ago

    Fuller, Smith & Turner PLC: Director / PDMR Shareholding

  • Published on 07/29/2026 at 18:07, 11 hours 31 minutes ago

    Quarterly Activities Report for the period ending 30 June 2026

View all EQS
Les Echos
  • Published on 07/29/2026 at 23:00, 6 hours 39 minutes ago

    BIOPHYTIS ANNOUNCES THE AUDITING OF ITS 2025 FINANCIAL STATEMENTS AND THE RESUMPTION OF TRADING IN ITS STOCK

  • Published on 07/29/2026 at 23:00, 6 hours 39 minutes ago

    Biophytis annonce la publication de ses comptes annuels 2025 et la reprise de la cotation de son action

  • Published on 07/29/2026 at 18:40, 10 hours 58 minutes ago

    Aéroports de Paris SA - Mise à disposition du rapport financier semestriel 2026

  • Published on 07/29/2026 at 18:40, 10 hours 58 minutes ago

    Aéroports de Paris SA - Availability of the 2026 financial interim report

  • Published on 07/29/2026 at 18:30, 11 hours 9 minutes ago

    Aéroports de Paris SA - Groupe ADP 2027-2034 Economic Regulation Agreement (ERA) project

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy